REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Statistics

Total Valuation

KRX:102460 has a market cap or net worth of KRW 196.62 billion. The enterprise value is 396.83 billion.

Market Cap	196.62B
Enterprise Value	396.83B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:102460 has 18.34 million shares outstanding.

Current Share Class	18.34M
Shares Outstanding	18.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	81.15%
Owned by Institutions (%)	3.15%
Float	2.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.31
PB Ratio	0.83
P/TBV Ratio	0.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-40.64
EV / Sales	2.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.91

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.88.

Current Ratio	0.61
Quick Ratio	0.34
Debt / Equity	0.88
Debt / EBITDA	67.33
Debt / FCF	-18.90
Interest Coverage	-2.22

Financial Efficiency

Return on equity (ROE) is -4.04% and return on invested capital (ROIC) is -2.33%.

Return on Equity (ROE)	-4.04%
Return on Assets (ROA)	-2.20%
Return on Invested Capital (ROIC)	-2.33%
Return on Capital Employed (ROCE)	-4.94%
Revenue Per Employee	341.03M
Profits Per Employee	-22.19M
Employee Count	312
Asset Turnover	0.31
Inventory Turnover	2.65

Taxes

In the past 12 months, KRX:102460 has paid 2.12 billion in taxes.

Income Tax	2.12B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.94% in the last 52 weeks. The beta is 0.58, so KRX:102460's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-33.94%
50-Day Moving Average	11,220.60
200-Day Moving Average	11,631.10
Relative Strength Index (RSI)	40.54
Average Volume (20 Days)	18,842

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:102460 had revenue of KRW 150.05 billion and -9.76 billion in losses. Loss per share was -533.00.

Revenue	150.05B
Gross Profit	55.30B
Operating Income	-17.03B
Pretax Income	-7.64B
Net Income	-9.76B
EBITDA	3.10B
EBIT	-17.03B
Loss Per Share	-533.00

Balance Sheet

The company has 8.64 billion in cash and 208.85 billion in debt, giving a net cash position of -200.21 billion or -10,915.98 per share.

Cash & Cash Equivalents	8.64B
Total Debt	208.85B
Net Cash	-200.21B
Net Cash Per Share	-10,915.98
Equity (Book Value)	236.97B
Book Value Per Share	12,920.07
Working Capital	-50.58B

Cash Flow

In the last 12 months, operating cash flow was -1.82 billion and capital expenditures -9.23 billion, giving a free cash flow of -11.05 billion.

Operating Cash Flow	-1.82B
Capital Expenditures	-9.23B
Free Cash Flow	-11.05B
FCF Per Share	-602.42

Margins

Gross margin is 36.85%, with operating and profit margins of -11.35% and -6.51%.

Gross Margin	36.85%
Operating Margin	-11.35%
Pretax Margin	-5.09%
Profit Margin	-6.51%
EBITDA Margin	2.07%
EBIT Margin	-11.35%
FCF Margin	n/a

Dividends & Yields

KRX:102460 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.97%
FCF Yield	-5.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 29, 2020
Split Type	Forward
Split Ratio	1.02

Scores

KRX:102460 has an Altman Z-Score of 1.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.24
Piotroski F-Score	3